| Code | CSB-MP008645MO1(F2) |
| Abbreviation | Recombinant Mouse Fgfr2 protein, partial (Active) |
| MSDS | |
| Size | $118 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
FGFR2 mediates critical signaling in development and tissue homeostasis, and its dysregulation drives oncogenesis in multiple epithelial cancers, making receptor-ligand interaction studies essential for therapeutic target validation. This mammalian-expressed construct spanning residues 39–263 of the short isoform captures the extracellular ligand-binding domain with native post-translational modifications that preserve conformational epitopes, as demonstrated by its specific binding to an anti-FGFR2 recombinant antibody with an EC50 of 2.084–2.249 ng/mL in functional ELISA. The quantified binding kinetics support its use in competitive inhibition assays for blocking antibody screening, therapeutic antibody epitope mapping, and small-molecule inhibitor discovery campaigns targeting the FGFR2 extracellular interface. Purity exceeding 95% by SDS-PAGE and endotoxin levels below 1.0 EU/μg meet the quality thresholds commonly required for surface plasmon resonance affinity characterization and biolayer interferometry studies where low background interference is critical.
There are currently no reviews for this product.